Wall Street’s Key Stock Analysts Research Reports

$ABBV, $AYX, $AMGN, $FBC, $GD, $NUAN, $TNDM, $VLO

Daily HeffX-LTN reviews dozens of  Wall Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.

Below is the list for Friday, 7 February, as follows:

AbbVie Inc. (NYSE:ABBV) was started with a Buy rating and a 96 target price at Mizuho. Shares have a 95.18 consensus target price.

Alteryx Inc.’s (NYSE:AYX) data analysis software is in high demand and this provider makes the science accessible to a wide variety of customers. Shares most recently closed at 135.21 and have a consensus price target of 130.14.

Amgen Inc. (NASDAQ:AMGN) was reiterated as Buy with a 265 target price at Argus. It has a 246.05 consensus target price.

Flagstar Bancorp Inc. (NYSE:FBC) was reiterated as Outperform with a 40 target price at Wedbush Securities.

General Dynamics Corp. (NYSE:GD) was raised to Overweight from Neutral and the target price was raised to 225 from 210 at JPMorgan. General Dynamics has a 210.39 consensus target price.

Nuance Communications Inc. (NASDAQ:NUAN): Wedbush reiterated its Outperform rating with a 27 target price, after the firm beat expectations on the Dragon Medical Cloud and seeing estimates beatable ahead.

Tandem Diabetes Care Inc. (NASDAQ:TNDM) was started as Outperform with an 85 target price at Raymond James. It has a 79.75 consensus target price.

Valero Energy Corp. (NYSE:VLO) was reiterated as Buy with a 110 target price at Argus. The stock has a consensus target price at 109.06.

Have a terrific weekend

#ABBV#AMGN#analysts#avoid#AYX#buy#FBC#GD#heffx#NUAN#price#sell#target#TNDM#trade#VLO#Wall Street